Document is current
Any future updates will be listed below
-
Authors
Takeshima, Takao
Wan, Qi
Zhang, Yanlei
Komori, Mika
Stretton, Serina
Rajan, Narayan
Treuer, Tamas
Ueda, Kaname http://orcid.org/0000-0003-1967-9829
-
Funding
Funding for this research was provided by:
Eli Lilly and Company (Not Applicable)
- License Information
-
More Information
Article History
Received: 15 August 2019
Accepted: 28 November 2019
First Online: 5 December 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: TTa reports grants and personal fees from AbbVie, Asahi Kasei, Amgen Astellas BioPharma, Bayer Yakuhin, Daiichi Sankyo, Eisai Co. Ltd., Eli Lilly Japan, FUJIFILM Toyama Chemical Co. Ltd., Kowa Pharmaceuticals, Janssen Pharmaceutic, Kyowa Hakko Kirin, Mitsubishi Tanabe Pharma, Ono Pharmaceutical Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Pfizer, Sawai Pharmaceutical Co. Ltd., and Takeda Pharmaceutical Co. Ltd. for speaker and consulting services unrelated to this publication. QW has no conflicts of interest to declare. KU, MK, YZ, NR, and TTr are employees of Eli Lilly and Company. TTr is a minor Eli Lilly shareholder. SS is an employee of ProScribe – Envision Pharma Group, a company that was funded by Eli Lilly and Company to provide medical writing support for this publication.
